Lecanemab (BAN-2401) is an IgG1 monoclonal antibody targeting soluble aggregated beta-amyloid (Abeta) with activity against oligomers, protofibrils, and insoluble protofibrils, and may be useful in the study of Alzheimers disease (AD)-induced mild cognitive
CAS Nummer:
[1260393-98-3]
Target-Kategorie:
Beta Amyloid
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten